(Q37948826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Ugo Moretti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Roberto Leone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

25 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

83-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22022824%20AND%20SRC:MED&resulttype=core&format=json

Adverse drug reactions: definitions, diagnosis, and management

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Classifying drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Detection of potential drug interactions - a model for a national pharmacy register

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Hospital admissions resulting from preventable adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Admissions to a medical intensive care unit related to adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Prospective evaluation of adverse drug interactions in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Hospitalisations and emergency department visits due to drug-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug interactions in oncology: how common are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Adverse drug reactions in hospitalized psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Predicting in vivo drug interactions from in vitro drug discovery data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Fatal drug-drug interaction of brivudine and capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug interactions and multiple drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Polypharmacy among nursing home geriatric Medicaid recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Polypharmacy in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

The challenge of managing drug interactions in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug interactions between antibiotics and select maintenance medications: seeing more clearly through the narrow therapeutic window of opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

The dosing of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug interaction and pharmacist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Codeine intoxication associated with ultrarapid CYP2D6 metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Important drug-drug interactions in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Clopidogrel-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Clopidogrel and proton pump inhibitors: a clinically meaningful interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Evaluation of contraindicated drug-drug interaction alerts in a hospital setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Pharmacogenetics, pharmacogenomics, and individualized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2012.631910